Attract talent

Aligos Therapeutics



Aligos Therapeutics is discovering and developing new classes of compounds that interact directly with disease causing molecules.


Add photos to showcase Aligos Therapeutics’s culture


Add Aligos Therapeutics’s values

Insider experiences

Share your experience of working at Aligos Therapeutics

Lawrence M. Blatt
Chief Executive Officer and Director
Leonid Beigelman
President and Director
Lucinda Y. Quan
EVP, Chief Business Officer and General Counsel
Julian A. Symons
EVP, Chief Scientific Officer
Matthew W. McClure
EVP, Chief Medical Officer
David B. Smith
EVP, Head of Chemical Operations
Pierre J.M.B. Raboisson
EVP, Head of Small Molecule Medicinal Chemistry, Head of Belgium Site (Leuven)
John Fry
EVP, Clinical Development
Sushmita M. Chanda
EVP, Translational Safety Sciences

Add your teams to show how people work together at Aligos Therapeutics

Add jobs to your org chart to show candidates who they’ll work with

Publish company announcements to get more exposure

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.